SCHEMBL515457

SCHEMBL515457

Cc1cc(OCc2ccccc2)cc(C)c1C1C(=O)C2C3CCC(CC3)C2C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 8/20 0.43
MAOA P21397 5/20 0.43
RAB9A P51151 3/20 0.43
NPC1 O15118 2/20 0.43
CASP3 P42574 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 3/20 0.42
NSD2 O96028 1/20 0.42
ABL1 P00519 1/20 0.42
PPARG P37231 1/20 0.42
RIN1 Q13671 1/20 0.42
NCOR2 Q9Y618 1/20 0.42
GRM5 P41594 2/20 0.41
S1PR1 P21453 1/20 0.41
S1PR5 Q9H228 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL515347 0.88 SRD5A1 (0.41) MAOBMAOARAB9ANPC1CASP3
SCHEMBL516169 0.85 MAOB (0.41) MAOBMAOARAB9ANPC1CASP3
SCHEMBL515937 0.84 MAOB (0.43) MAOBMAOARAB9ANPC1CASP3
SCHEMBL515854 0.84 MAOB (0.43) MAOBMAOARAB9ANPC1CASP3
SCHEMBL516265 0.80 TOP1 (0.49) MAOBMAOARAB9ANPC1CASP3
SCHEMBL403344 0.79 MAOB (0.53) MAOBMAOARAB9ANPC1CASP3
SCHEMBL10187572 0.75 FFAR1 (0.42) MAOBMAOARAB9ANPC1CASP3
SCHEMBL8901906 0.74 MAOB (0.56) MAOBMAOARAB9ANPC1CASP3
Hydrochloric Acid SCHEMBL29763734 0.73 MAOB (0.55) MAOBMAOARAB9ANPC1CASP3
Hydrochloric Acid SCHEMBL28293182 0.73 MAOB (0.55) MAOBMAOARAB9ANPC1CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6989264-B2 Methods for generating high titer helper-free preparations of released recombinant AAV vectors TARGETED GENETICS CORPORATION (US) 2006-01-24 US claimed
EP-2393769-B1 NOVEL HERBICIDES SYNGENTA LTD (GB) 2014-12-10 EP disclosed
US-8680339-B2 Herbicides SYNGENTA LIMITED (GB) 2014-03-25 US disclosed
US-20120028800-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-02-02 US disclosed
EP-2393769-A1 NOVEL HERBICIDES Syngenta Limited (GB) 2011-12-14 EP disclosed
US-7816320-B2 Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35 AMBRX, INC. (US) 2010-10-19 US disclosed
WO-2010089210-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2010-08-12 WO disclosed
US-20060135427-A1 Formulations of human growth hormone comprising a non-naturally encoded amino acid AMBRX, INC. (US) 2006-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135427-A1 Formulations of human growth hormone comprising a non-naturally encoded amino acid GHRHR, GHITM, GHSR MAOB 3362/4885MAOA 3795/4885RAB9A 3594/4885
US-20120028800-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 MAOB 2064/4885MAOA 2359/4885RAB9A 3044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.